MeSH term
Frequency | Condition_Probility | Humans | 164 | 0.0 |
Animals | 136 | 0.0 |
Gene Expression | 13 | 0.0 |
Adenoviridae/genetics | 2 | 0.0 |
Base Sequence | 49 | 0.0 |
Cartilage/metabolism | 2 | 6.0 |
Cell Differentiation | 12 | 0.0 |
Cell Line | 14 | 0.0 |
Chondrocytes/cytology/metabolism | 2 | 16.0 |
DNA-Binding Proteins/metabolism | 8 | 0.0 |
Enhancer Elements (Genetics) | 3 | 0.0 |
Hela Cells | 2 | 0.0 |
High Mobility Group Proteins/metabolism/*physiology | 2 | 50.0 |
Luciferases/metabolism | 2 | 0.0 |
Molecular Sequence Data | 60 | 0.0 |
Nuclear Proteins/metabolism | 4 | 0.0 |
Plasmids/metabolism | 2 | 0.0 |
Protein Binding | 7 | 0.0 |
Protein Structure, Tertiary | 5 | 0.0 |
Research Support, Non-U.S. Gov't | 129 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 16 | 0.0 |
Time Factors | 8 | 0.0 |
Transcription Factors/metabolism/*physiology | 2 | 2.0 |
Transfection | 19 | 0.0 |
Adult | 14 | 0.0 |
Aged | 3 | 0.0 |
Blotting, Northern | 7 | 0.0 |
Cell Differentiation/physiology | 4 | 0.0 |
Female | 74 | 0.0 |
Gene Expression Profiling | 7 | 0.0 |
Gene Expression Regulation, Neoplastic | 3 | 0.0 |
High Mobility Group Proteins/biosynthesis/*genetics | 3 | 25.0 |
Male | 101 | 0.0 |
Middle Aged | 8 | 0.0 |
Oligonucleotide Array Sequence Analysis | 3 | 0.0 |
RNA, Messenger/metabolism | 3 | 0.0 |
Sequence Analysis, DNA | 10 | 0.0 |
Transcription Factors/biosynthesis/*genetics | 3 | 2.0 |
Alkaline Phosphatase/metabolism | 2 | 1.0 |
Cell Movement | 2 | 0.0 |
Chondrocytes/*metabolism | 4 | 12.0 |
DNA, Complementary/metabolism | 2 | 0.0 |
*Gene Expression Regulation, Developmental | 17 | 2.0 |
Immunohistochemistry | 12 | 0.0 |
Microscopy, Fluorescence | 3 | 0.0 |
Mutation | 19 | 0.0 |
Sialoglycoproteins/metabolism | 2 | 4.0 |
Signal Transduction | 7 | 0.0 |
Conserved Sequence | 5 | 0.0 |
DNA Footprinting | 2 | 0.0 |
High Mobility Group Proteins/*metabolism | 7 | 21.0 |
Mice | 72 | 0.0 |
Organ Specificity | 7 | 0.0 |
Polymerase Chain Reaction | 10 | 0.0 |
Promoter Regions (Genetics)/genetics | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 35 | 0.0 |
*Sex Determination (Genetics) | 27 | 50.0 |
Sex Differentiation | 8 | 36.0 |
*Trans-Activation (Genetics) | 4 | 0.0 |
Transcription Factors/*metabolism | 8 | 0.0 |
Transcription Initiation Site | 2 | 1.0 |
Cloning, Molecular | 10 | 0.0 |
DNA Primers | 9 | 0.0 |
*Gene Expression Regulation | 6 | 0.0 |
Kinetics | 3 | 0.0 |
Promoter Regions (Genetics) | 8 | 0.0 |
Rats | 9 | 0.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
*Transcription Factors | 6 | 0.0 |
Biological Markers | 5 | 0.0 |
High Mobility Group Proteins/genetics/*metabolism | 9 | 37.0 |
In Situ Hybridization | 17 | 0.0 |
Nerve Tissue Proteins/metabolism | 2 | 0.0 |
Transcription Factors/genetics/*metabolism | 9 | 1.0 |
DNA-Binding Proteins/*genetics/metabolism | 2 | 0.0 |
Gestational Age | 2 | 0.0 |
High Mobility Group Proteins/*genetics/metabolism | 5 | 38.0 |
*Nuclear Proteins | 30 | 1.0 |
Sex Differentiation/genetics | 5 | 27.0 |
Transcription Factors/*genetics/metabolism | 5 | 1.0 |
*Y Chromosome | 3 | 2.0 |
Embryonic and Fetal Development/genetics | 3 | 3.0 |
Ovary/embryology | 3 | 23.0 |
Testis/embryology | 8 | 36.0 |
X Chromosome | 4 | 0.0 |
Y Chromosome | 5 | 5.0 |
High Mobility Group Proteins/*genetics | 37 | 41.0 |
Sex Determination (Genetics) | 15 | 41.0 |
Sex Differentiation/*genetics | 13 | 48.0 |
Testis/*embryology | 3 | 30.0 |
Transcription Factors/*genetics | 37 | 1.0 |
DNA-Binding Proteins/genetics | 11 | 1.0 |
Mammals | 4 | 1.0 |
Sex Reversal, Gonadal | 12 | 50.0 |
Comparative Study | 12 | 0.0 |
High Mobility Group Proteins/genetics | 15 | 42.0 |
Receptors, Retinoic Acid/genetics | 3 | 3.0 |
*Repressor Proteins | 10 | 0.0 |
Transcription Factors/genetics | 14 | 1.0 |
Genotype | 5 | 0.0 |
*Glycoproteins | 5 | 0.0 |
Growth Inhibitors/metabolism | 2 | 6.0 |
Phenotype | 19 | 0.0 |
Sex Differentiation/*physiology | 6 | 54.0 |
*Sex Reversal, Gonadal | 14 | 31.0 |
Testicular Hormones/metabolism | 2 | 100.0 |
Cell Lineage | 2 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 5 | 0.0 |
Genes, Reporter | 4 | 0.0 |
Mice, Transgenic | 9 | 0.0 |
Nuclear Proteins/genetics/*metabolism | 3 | 0.0 |
Recombinant Fusion Proteins/genetics/metabolism | 5 | 0.0 |
Transgenes | 2 | 0.0 |
*Up-Regulation | 2 | 0.0 |
Fishes | 2 | 2.0 |
Gene Expression Regulation, Developmental | 11 | 1.0 |
Sertoli Cells/metabolism | 4 | 20.0 |
Testicular Hormones/*genetics | 2 | 14.0 |
Testis/embryology/metabolism | 3 | 27.0 |
Collagen Type II/genetics | 5 | 45.0 |
*Extracellular Matrix Proteins | 6 | 4.0 |
RNA, Messenger/analysis | 7 | 0.0 |
Amino Acid Sequence | 42 | 0.0 |
Chickens | 6 | 0.0 |
*Genes, sry | 3 | 30.0 |
Introns | 2 | 0.0 |
Phylogeny | 3 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 8 | 0.0 |
Gene Expression Regulation | 13 | 0.0 |
Species Specificity | 4 | 0.0 |
Cell Line, Tumor | 2 | 0.0 |
Mice, Inbred BALB C | 2 | 0.0 |
Proteins/genetics | 5 | 0.0 |
Sequence Homology, Nucleic Acid | 8 | 0.0 |
Bone Diseases, Developmental/genetics | 5 | 45.0 |
Chondrocytes/*physiology | 3 | 21.0 |
Binding Sites | 8 | 0.0 |
DNA/metabolism | 5 | 0.0 |
Gene Expression Regulation/*drug effects | 2 | 0.0 |
Mutagenesis, Site-Directed | 3 | 0.0 |
Rats, Sprague-Dawley | 3 | 0.0 |
Morphogenesis | 2 | 0.0 |
Sequence Alignment | 15 | 0.0 |
Sex Differentiation/physiology | 3 | 33.0 |
Child, Preschool | 6 | 0.0 |
Infant | 4 | 0.0 |
Infant, Newborn | 12 | 0.0 |
Chromosome Mapping | 13 | 0.0 |
Databases, Factual | 2 | 0.0 |
*Gene Deletion | 3 | 0.0 |
Pedigree | 4 | 0.0 |
Translocation, Genetic | 5 | 0.0 |
Cattle | 4 | 0.0 |
Cell Culture Techniques/methods | 2 | 0.0 |
Cell Differentiation/genetics | 3 | 1.0 |
Cells, Cultured | 14 | 0.0 |
Chondrocytes/cytology/*metabolism | 2 | 12.0 |
Fetus | 3 | 0.0 |
Y Chromosome/genetics | 7 | 23.0 |
Cell Line, Transformed | 3 | 0.0 |
Chromosomes, Human, Pair 17/*genetics | 3 | 1.0 |
Conserved Sequence/genetics | 3 | 1.0 |
Sequence Homology, Amino Acid | 15 | 0.0 |
Chondrocytes/*cytology | 2 | 12.0 |
DNA-Binding Proteins/*genetics | 12 | 0.0 |
Gene Transfer Techniques | 2 | 0.0 |
Kidney/cytology | 2 | 1.0 |
Proteoglycans/genetics | 2 | 8.0 |
Exons/genetics | 2 | 0.0 |
Introns/genetics | 3 | 0.0 |
3T3 Cells | 4 | 0.0 |
DNA Mutational Analysis | 4 | 0.0 |
Tumor Cells, Cultured | 8 | 0.0 |
Genetic Vectors | 2 | 0.0 |
Models, Genetic | 3 | 0.0 |
Mutagenesis | 2 | 0.0 |
Tissue Distribution | 3 | 0.0 |
beta-Galactosidase/metabolism | 3 | 1.0 |
Gonads/*embryology/metabolism | 2 | 66.0 |
Temperature | 5 | 0.0 |
DNA-Binding Proteins/*genetics/physiology | 4 | 4.0 |
High Mobility Group Proteins/*genetics/physiology | 7 | 77.0 |
Models, Biological | 2 | 0.0 |
Receptors, Retinoic Acid/genetics/physiology | 4 | 36.0 |
Regulatory Sequences, Nucleic Acid | 4 | 0.0 |
*Sex Characteristics | 2 | 1.0 |
Transcription Factors/*genetics/physiology | 8 | 8.0 |
Chick Embryo | 7 | 1.0 |
Gene Library | 4 | 0.0 |
Transcription, Genetic | 11 | 0.0 |
High Mobility Group Proteins/chemistry/*genetics | 6 | 46.0 |
Osteochondrodysplasias/*genetics | 10 | 12.0 |
*Point Mutation | 3 | 0.0 |
Transcription Factors/chemistry/*genetics | 6 | 6.0 |
Cell Differentiation/*physiology | 4 | 1.0 |
Blotting, Western | 3 | 0.0 |
Precipitin Tests | 2 | 0.0 |
*Evolution, Molecular | 2 | 0.0 |
Cell Division/physiology | 5 | 0.0 |
Transcription Factors/genetics/metabolism | 5 | 1.0 |
Bone and Bones/*abnormalities | 7 | 33.0 |
Chondrocytes/physiology | 3 | 50.0 |
Mesoderm/physiology | 2 | 5.0 |
Mice, Inbred C57BL | 7 | 0.0 |
*Mutation | 9 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 3 | 0.0 |
Gene Deletion | 2 | 0.0 |
Trans-Activation (Genetics) | 6 | 0.0 |
*Sex Differentiation | 4 | 44.0 |
High Mobility Group Proteins/biosynthesis/genetics | 2 | 50.0 |
Transcription Factors/biosynthesis/genetics | 2 | 2.0 |
*Transforming Growth Factor beta | 3 | 2.0 |
COS Cells | 8 | 0.0 |
Cell Nucleus/metabolism | 4 | 0.0 |
DNA/*metabolism | 2 | 0.0 |
Genes, Dominant | 3 | 0.0 |
Karyotyping | 6 | 0.0 |
Polymorphism, Single-Stranded Conformational | 3 | 0.0 |
Zinc Fingers | 2 | 0.0 |
Sertoli Cells/physiology | 2 | 14.0 |
*Sex Differentiation/genetics | 2 | 100.0 |
Gonads/embryology | 3 | 37.0 |
Receptors, Retinoic Acid/*genetics | 2 | 3.0 |
X Chromosome/genetics | 3 | 1.0 |
Chondrocytes/cytology | 2 | 16.0 |
Cell Division/drug effects | 4 | 0.0 |
Collagen/metabolism | 2 | 0.0 |
High Mobility Group Proteins/metabolism | 4 | 20.0 |
Mice, Nude | 2 | 0.0 |
Tissue Engineering | 2 | 18.0 |
Transcription Factors/metabolism | 3 | 0.0 |
Chromosomes, Human, Pair 17/genetics | 4 | 2.0 |
*DNA Mutational Analysis | 2 | 1.0 |
DNA Primers/chemistry | 2 | 0.0 |
Gonadal Dysgenesis, 46,XY/genetics | 2 | 33.0 |
Osteochondrodysplasias/*genetics/radiography | 2 | 15.0 |
Evolution, Molecular | 7 | 0.0 |
Mutation/genetics | 2 | 0.0 |
Gonadal Dysgenesis, 46,XY/*genetics | 2 | 22.0 |
Alleles | 2 | 0.0 |
Polymorphism, Restriction Fragment Length | 3 | 0.0 |
Sequence Deletion/genetics | 2 | 1.0 |
Syndrome | 3 | 0.0 |
DNA-Binding Proteins/genetics/physiology | 3 | 3.0 |
High Mobility Group Proteins/genetics/*physiology | 2 | 22.0 |
Transcription Factors/genetics/*physiology | 2 | 1.0 |
*Chromosome Mapping | 4 | 0.0 |
English Abstract | 4 | 0.0 |
Chromosomes, Artificial, Yeast | 2 | 0.0 |
RNA/metabolism | 2 | 0.0 |
Trans-Activators/metabolism | 2 | 0.0 |
Bone Morphogenetic Proteins/metabolism | 2 | 3.0 |
Signal Transduction/*physiology | 4 | 0.0 |
Cartilage/cytology/*metabolism | 2 | 15.0 |
Cercopithecus aethiops | 2 | 0.0 |
DNA, Complementary/genetics | 2 | 0.0 |
Green Fluorescent Proteins | 2 | 0.0 |
In Situ Hybridization, Fluorescence | 8 | 0.0 |
*Promoter Regions (Genetics) | 6 | 0.0 |
Transcription Factors/physiology | 2 | 0.0 |
WT1 Proteins | 5 | 1.0 |
DNA, Complementary | 4 | 0.0 |
DNA-Binding Proteins/genetics/metabolism | 3 | 0.0 |
High Mobility Group Proteins/genetics/metabolism | 2 | 20.0 |
Mice, Knockout | 3 | 0.0 |
Nuclear Proteins/genetics/metabolism | 2 | 1.0 |
Ovary/growth & development | 3 | 50.0 |
Microsatellite Repeats | 3 | 0.0 |
Cartilage/*metabolism | 2 | 10.0 |
Collagen/*biosynthesis/genetics | 2 | 11.0 |
Disease Models, Animal | 3 | 0.0 |
Fracture Healing/*physiology | 2 | 25.0 |
High Mobility Group Proteins/biosynthesis/genetics/*physiology | 2 | 100.0 |
*Protein Biosynthesis | 2 | 0.0 |
Transcription Factors/biosynthesis/genetics/*physiology | 2 | 8.0 |
Bone Morphogenetic Proteins/*physiology | 3 | 13.0 |
Chondrogenesis/*physiology | 4 | 50.0 |
High Mobility Group Proteins/*physiology | 3 | 25.0 |
Transcription Factors/*physiology | 3 | 0.0 |
Child | 4 | 0.0 |
High Mobility Group Proteins/chemistry/*genetics/physiology | 2 | 100.0 |
Models, Molecular | 2 | 0.0 |
Phosphorylation | 2 | 0.0 |
Adolescent | 4 | 0.0 |
Chromosomes, Human, Pair 17 | 2 | 0.0 |
Exons | 3 | 0.0 |
Sequence Tagged Sites | 2 | 0.0 |
*Translocation, Genetic | 2 | 0.0 |
Multigene Family | 3 | 0.0 |
Gonads/*embryology | 2 | 22.0 |
RNA, Messenger/genetics/metabolism | 3 | 0.0 |
Alginates | 3 | 37.0 |
Chondrocytes/cytology/*physiology | 2 | 28.0 |
Glucuronic Acid | 3 | 15.0 |
Hexuronic Acids | 3 | 30.0 |
Microspheres | 2 | 1.0 |
Collagen/genetics | 2 | 2.0 |
*Enhancer Elements (Genetics) | 2 | 0.0 |
Sex Differentiation/genetics/physiology | 2 | 40.0 |
Transcription Factors/genetics/physiology | 2 | 3.0 |
Consensus Sequence/genetics | 2 | 4.0 |
DNA-Binding Proteins/*metabolism | 2 | 0.0 |
Trans-Activation (Genetics)/genetics | 2 | 2.0 |
Genetic Markers | 4 | 0.0 |
Polymorphism, Genetic | 3 | 0.0 |
Bone Development/*physiology | 2 | 11.0 |
Embryo/cytology | 2 | 2.0 |
Embryonic and Fetal Development | 8 | 2.0 |
*Neoplasm Proteins | 2 | 0.0 |
Homeodomain Proteins/genetics | 2 | 0.0 |
Pregnancy | 4 | 0.0 |
Mice, Mutant Strains | 4 | 0.0 |
DNA-Binding Proteins/biosynthesis | 2 | 2.0 |
High Mobility Group Proteins/*biosynthesis | 3 | 75.0 |
Trans-Activators/biosynthesis | 2 | 5.0 |
Transcription Factors/*biosynthesis | 4 | 3.0 |
Proteoglycans/biosynthesis/genetics | 2 | 25.0 |
Collagen/*genetics | 2 | 0.0 |
Gene Expression Regulation, Developmental/*physiology | 2 | 1.0 |
Cartilage/*embryology | 2 | 28.0 |
Sequence Deletion | 2 | 0.0 |
Neoplasm Proteins/genetics | 2 | 0.0 |
Receptors, Androgen/genetics | 2 | 3.0 |
*Chromosomes, Human, Pair 17 | 3 | 0.0 |
Hamsters | 2 | 0.0 |
Hybrid Cells | 2 | 0.0 |
Open Reading Frames | 2 | 0.0 |
Testis/cytology/*embryology | 2 | 100.0 |
Sex Determination (Analysis) | 2 | 6.0 |
Genes | 2 | 0.0 |
*Sex Determination (Analysis) | 3 | 9.0 |
Nuclear Proteins/genetics | 2 | 0.0 |
Gene Dosage | 2 | 0.0 |
Chromosome Disorders | 2 | 0.0 |
Sex Differentiation Disorders/genetics | 2 | 40.0 |
Molecular Biology | 2 | 0.0 |
Testis/growth & development | 2 | 22.0 |
Sex Differentiation Disorders/*genetics | 2 | 16.0 |
Glycoproteins/genetics | 2 | 2.0 |
*Protein-Tyrosine Kinase | 2 | 0.0 |
Osteogenesis | 2 | 8.0 |
DNA-Binding Proteins/chemistry/genetics/*physiology | 2 | 5.0 |
Transcription Factors/chemistry/genetics/*physiology | 2 | 7.0 |
Mammals/*genetics | 2 | 5.0 |
Interleukin-1/pharmacology | 2 | 0.0 |
Cell Culture Techniques | 2 | 0.0 |
Administration, Inhalation | 2 | 1.0 |
Aerosols | 2 | 2.0 |
Calibration | 2 | 1.0 |
Equipment Design | 2 | 1.0 |
*Metered Dose Inhalers | 2 | 20.0 |
*Nebulizers and Vaporizers | 2 | 10.0 |
Particle Size | 2 | 0.0 |
Technology, Pharmaceutical | 2 | 18.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Estradiol/pharmacology | 2 | 0.0 |
Up-Regulation | 2 | 0.0 |
Extremities/*embryology | 2 | 6.0 |
Collagen Type II/*genetics | 4 | 18.0 |
Mice, Inbred C3H | 2 | 0.0 |
Gene Expression Regulation/drug effects | 2 | 0.0 |
Recombinant Proteins/pharmacology | 2 | 0.0 |
Recombinant Fusion Proteins/metabolism | 2 | 0.0 |
DNA-Binding Proteins/*biosynthesis | 2 | 1.0 |
High Mobility Group Proteins/biosynthesis | 2 | 50.0 |
